-

Stanford Health Care, Stanford Health Care – ValleyCare Earn As in Patient Safety During COVID-19 Surge

The Leapfrog Group, an organization that rates U.S. hospitals for patient safety, gave A grades to Stanford Health Care and Stanford Health Care – ValleyCare during the months the hospitals saw their highest numbers of COVID-19 patients.

PALO ALTO, Calif.--(BUSINESS WIRE)--This winter, even as the number of COVID-19 patients peaked at Stanford Health Care and Stanford Health Care – ValleyCare, both hospitals achieved excellent patient safety grades from a leading watchdog organization.

The Leapfrog Group gave each hospital an A for avoiding medical errors and other preventable harm during the latest grading period, which ran from December 2020 to April 2021. On Jan. 3, Stanford Health Care had its highest number of patients in the hospital because of COVID-19, while ValleyCare experienced its peak on Dec. 28.

“During the most severe health crisis of our generation, the people of Stanford Health Care continue to shine,” said David Entwistle, president and CEO of Stanford Health Care. “This achievement, amid the unprecedented challenges of a global pandemic, is a testament to their unwavering dedication to delivering exemplary patient care. I couldn’t be prouder of our incredible staff, who work tirelessly every day to lift the health of our community.”

Leapfrog, a national nonprofit that publishes hospital-safety assessments twice yearly, announced the grades April 29. The organization evaluates more than 2,600 acute-care hospitals each winter and spring, grading them on measures such as staffing levels, administration of medication, patient falls and how quickly staff respond to patient needs.

“We are pleased that the Leapfrog Group has recognized Stanford Health Care – ValleyCare with an A rating for spring of 2021,” said Rick Shumway, president and CEO of Stanford Health Care – ValleyCare. “This honor celebrates the dedication and commitment throughout our organization to providing the highest quality of care to our community.”

“I’m incredibly proud of our team and their dedication to safety, quality and patient satisfaction, especially during this past year with the challenges of the Covid-19 pandemic,” he added.

The Stanford University School of Medicine consistently ranks among the nation’s top medical schools, integrating research, medical education, patient care and community service. For more news about the school, please visit http://med.stanford.edu/school.html. The medical school is part of Stanford Medicine, which includes Stanford Health Care and Stanford Children’s Health. For information about all three, please visit http://med.stanford.edu.

Contacts

Courtney Lodato
(650) 213-2217
clodato@stanfordhealthcare.org

Stanford Health Care Logo
Stanford Health Care Logo

Stanford Health Care


Release Versions

Contacts

Courtney Lodato
(650) 213-2217
clodato@stanfordhealthcare.org

More News From Stanford Health Care

Stanford Medicine to Launch the Patients Like MineSM Suite of Services, Empowering Community Physicians with Data and Reference Solutions

STANFORD, Calif.--(BUSINESS WIRE)--Stanford Medicine is launching the Patients Like MineSM, suite of services specifically designed to equip community physicians in diverse practice settings with the data and reference solutions to assist them in delivering evidence-based, high-quality care to their patients. Patients Like MineSM services will enable community physicians to leverage Stanford Medicine’s digital tools, large language models and artificial intelligence-enabled services while prese...

Stanford Medicine and Northpond Ventures Announce the Launch of The Northpond Laboratories - Program for Research and Innovation at Stanford Medicine

STANFORD, Calif.--(BUSINESS WIRE)--Stanford Medicine and Northpond Ventures announced the launch of The Northpond Laboratories - Program for Research and Innovation at Stanford Medicine. The program seeks to identify and build upon the scientific discoveries and innovations developed by Stanford Medicine's leading faculty and researchers and accelerate the pace of translation between scientific research to clinical and commercial applications that improve patient outcomes through the vehicle of...

Stanford University’s Innovative Medicines Accelerator and Intonation Research Laboratories (Intonation) form a collaboration to fight cancerous neuroendocrine tumors

STANFORD, Calif.--(BUSINESS WIRE)--Stanford University’s Innovative Medicines Accelerator (IMA) and Intonation Research Laboratories (Intonation) have formed a collaboration to develop treatments that target cancerous neuroendocrine tumors, or tumors that form from hormone-releasing cells. The goal of the collaboration is to reduce the time and resources it takes to translate a biomedical breakthrough into a clinically and commercially viable medicine. “I’m excited about this collaboration with...
Back to Newsroom